111 related articles for article (PubMed ID: 2042458)
1. DNA content prognostic in soft tissue sarcoma. 102 patients followed for 1-10 years.
Bauer HC; Kreicbergs A; Tribukait B
Acta Orthop Scand; 1991 Jun; 62(3):187-94. PubMed ID: 2042458
[TBL] [Abstract][Full Text] [Related]
2. Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience.
Alvegard TA; Berg NO; Baldetorp B; Fernö M; Killander D; Ranstam J; Rydholm A; Akerman M
J Clin Oncol; 1990 Mar; 8(3):538-47. PubMed ID: 2407813
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of newer prognostic markers for adult soft tissue sarcomas.
Levine EA; Holzmayer T; Bacus S; Mechetner E; Mera R; Bolliger C; Roninson IB; Das Gupta TK
J Clin Oncol; 1997 Oct; 15(10):3249-57. PubMed ID: 9336362
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric DNA content analysis of 185 soft tissue neoplasms indicates that S-phase fraction is a prognostic factor for sarcomas. French Federation of Cancer Centers (FNCLCC) Sarcoma Group.
Collin F; Chassevent A; Bonichon F; Bertrand G; Terrier P; Coindra JM
Cancer; 1997 Jun; 79(12):2371-9. PubMed ID: 9191525
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients.
Dreinhöfer KE; Baldetorp B; Akerman M; Fernö M; Rydholm A; Gustafson P
Cytometry; 2002 Feb; 50(1):19-24. PubMed ID: 11857594
[TBL] [Abstract][Full Text] [Related]
6. Prognosis for soft-tissue sarcoma in the locomotor system. A retrospective population-based follow-up study of 237 patients.
Rydholm A; Berg NO; Gullberg B; Persson BM; Thorngren KG
Acta Pathol Microbiol Immunol Scand A; 1984 Sep; 92(5):375-86. PubMed ID: 6507102
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients.
Iqbal N; Shukla NK; Deo SV; Agarwala S; Sharma DN; Sharma MC; Bakhshi S
Clin Transl Oncol; 2016 Mar; 18(3):310-6. PubMed ID: 26243399
[TBL] [Abstract][Full Text] [Related]
8. Prognosis in high-grade soft tissue sarcomas. The Scandinavian Sarcoma Group experience in a randomized adjuvant chemotherapy trial.
Alvegård TA; Berg NO; Ranstam J; Rydholm A; Rööser B
Acta Orthop Scand; 1989 Oct; 60(5):517-21. PubMed ID: 2690557
[TBL] [Abstract][Full Text] [Related]
9. Forearm soft tissue sarcoma: tumors characteristics and oncologic outcomes following limb salvage surgery.
Baroudi MR; Ferguson PC; Wunder JS; Isler MH; Mottard S; Werier JA; Turcotte RE
J Surg Oncol; 2014 Nov; 110(6):676-81. PubMed ID: 24910319
[TBL] [Abstract][Full Text] [Related]
10. Survival in soft tissue sarcoma. Prognostic variables identified by multivariate analysis.
Rööser B; Attewell R; Berg NO; Rydholm A
Acta Orthop Scand; 1987 Oct; 58(5):516-22. PubMed ID: 3425281
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma.
Vaynrub M; Taheri N; Ahlmann ER; Yao C; Fedenko AN; Allison DC; Chawla SP; Menendez LR
J Surg Oncol; 2015 Feb; 111(2):152-7. PubMed ID: 25175933
[TBL] [Abstract][Full Text] [Related]
12. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.
Gustafson P
Acta Orthop Scand Suppl; 1994 Jun; 259():1-31. PubMed ID: 8042499
[TBL] [Abstract][Full Text] [Related]
13. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.
Weitz J; Antonescu CR; Brennan MF
J Clin Oncol; 2003 Jul; 21(14):2719-25. PubMed ID: 12860950
[TBL] [Abstract][Full Text] [Related]
14. Epithelioid sarcoma. Flow cytometric study of DNA content and regional DNA heterogeneity.
el-Naggar AK; Garcia GM
Cancer; 1992 Apr; 69(7):1721-8. PubMed ID: 1551057
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in soft tissue sarcoma. A review and the Scandinavian Sarcoma Group experience.
Rydholm A; Gustafson P; Alvegård TA; Saeter G; Blomqvist C
Acta Orthop Scand Suppl; 1999 Jun; 285():50-7. PubMed ID: 10429623
[No Abstract] [Full Text] [Related]
16. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma.
Singer S; Corson JM; Gonin R; Labow B; Eberlein TJ
Ann Surg; 1994 Feb; 219(2):165-73. PubMed ID: 8129487
[TBL] [Abstract][Full Text] [Related]
17. S-phase fraction of 155 soft tissue sarcomas: correlation with clinical outcome.
Huuhtanen RL; Blomqvist CP; Wiklund TA; Virolainen MJ; Elomaa AI; Pan Y; Tribukait B
Cancer; 1996 May; 77(9):1815-22. PubMed ID: 8646679
[TBL] [Abstract][Full Text] [Related]
18. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Relevant Clinicopathologic Variables in Epithelioid Sarcoma: A Multi-Institutional Retrospective Study of 44 Patients.
Asano N; Yoshida A; Ogura K; Kobayashi E; Susa M; Morioka H; Iwata S; Ishii T; Hiruma T; Chuman H; Kawai A
Ann Surg Oncol; 2015 Aug; 22(8):2624-32. PubMed ID: 25663591
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas.
Kraus DH; Dubner S; Harrison LB; Strong EW; Hajdu SI; Kher U; Begg C; Brennan MF
Cancer; 1994 Jul; 74(2):697-702. PubMed ID: 8033050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
